SK Bioscience has announced that its COVID-19 vaccine, SKYCovione, has been granted Emergency Use Listing by the World Health Organisation.
SKYCovione is a self-assembled nanoparticle vaccine that specifically targets the receptor binding domain of the SARS-CoV-2 Spike protein, which is responsible for the virus's entry into human cells. Based on the immunogenicity and safety profile, SKYCovione becomes the 12th COVID-19 vaccine to be granted Emergency Use Listing.
SKYCovione is the world
